SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-147157
Filing Date
2024-05-24
Accepted
2024-05-24 17:00:59
Documents
1
Group Members
FLAGSHIP PIONEERING FUND VII GENERAL PARTNER LLCFLAGSHIP PIONEERING FUND VII, L.PFLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II GENERAL PARTNER LLCFLAGSHIP PIONEERING SPECIAL OPPORTUNITIES FUND II, L.PFLAGSHIP PIONEERING, INCFLAGSHIP VENTURES FUND V GE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d840889dsc13da.htm SC 13D/A 197037
  Complete submission text file 0001193125-24-147157.txt   199167
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Subject) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91795 | Film No.: 24985341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)